You just read:

ASPiRA LABS' OVA1 Technology Receives "Level B" Recommendation in the Latest ACOG Clinical Management Guidelines for the Management of Adnexal Masses

News provided by

Vermillion, Inc.

Nov 09, 2016, 16:05 ET